Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
VYCO needs more bid action to close up that spread
How's the bid support looking?
Slow day, nice to see VYCO holding its own at.018 but I'd like to see that spread close up and some more volume.
Morning, VYCO stock studs! How we looking today?
$$VYCO nice ask slap again to start the day
Not a bad day...VYCO is just fundamentally strong. The Story will come through and we will see growth imho
I believe the agreement with the inside holders is that they won't sell until .08
I am glad I hung on while the road was rough for there show be plenty of profits to cool my rockets this fall
To add float is large 840 mill however 64% I believe is locked up and cannot be traded until 5
VYCO is strong like Thundercleese
It seems to really like floating between .18-.21 If you watch very closely you may get a good hand full on the dip.
Bid sitters are going to need to reach across and tap NITE on .018 to get this moving again
There must be some good support on the bid.
ya just that one major seller once gone it rolls fast and hard on any news..
2 mm's till 2's, ATDF is stacked, but a few good pushes by longs should bust through
$$VYCO one more ask smack to start the day looking stronger
Morning, stock studs! Yup, "tremendous bargain" is what I'd call it, too. No way this stock's worth less than .05/share right now, that's for sure.
VYCO: tremendous bargain at this level. Looking forward to seeing what it does today.
Over 60% of the float is locked up and can't be sold before 6 cents. Lots of room for investors to make and take profit between here and there ;-D
Vycor is such a focused company: 2 unique neurology product offerings, both FDA approved, on the cutting edge of medical science, with strong support from the scientific community and already penetrating worldwide markets. This is the time to pick up some VYCO
Good conference call. That guy Denness knows his stuff, that's for sure. And the venture capital fellow has a lot of confidence in what Vycor's doing, too.
From the conference call: the VBAS product for brain surgery can be used with MRI technology since there is no metal in the product. Saves the hospital big bucks
Conference Call right now: learn more about vyco from the ceo
4:00pm est
Conference Call
Conference Dial-in Number: (605) 475-4000
Participant Access Code: 955724#
KKP
Looking good all day, so far, though I wish volume were better. But still, if it's good volume that's more valuable than all that churn volume.
Nice to see that spread close up, we need some more support at the bid
I believe they have been saying Oct. Nov. we might see some big growth.
KKP
.019, nice to see VYCO starting the day green
$$VYCO nice hit for 10k shares at .019 to start the day..looking good
Yup, good volume yesterday and maybe the company's getting eyes on it that'll bring it nothing but fair winds and following seas in the near future! Go VYCO!
Some nice volume yesterday, lets see if that ASK gets hit out the gate today
.017 x .019. ATDF is stacked
Well, good volume at least. It's red, but better red than dead, eh?
$$VYCO and there they go..great start to the week..
Time to knock out those .017's. 1 mm to .019
Looks like some new investors gettin their feet wet today.
Yup, stevo...this one'll be doing fine soon enough.
$$VYCO nice bid ask nice to see for sure.
Konnichi wa, stock samurai! Another week with VYCO is like another week in the Caribbean sunshine, babes.
Morning Vyconians! New start, new week. Want to see those 2's back pronto ;-D
come on man...well at least .018 but volume is so low its hard to move anything
Pretty quiet day so far. But Denness is our man, and he'll be getting the job done, I really believe.
Normally some volatility, a weekend beer money sale, followed by a strong close *fingers crossed*
Friday afternoon has traditionally been strong for us
Followers
|
33
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2964
|
Created
|
10/06/09
|
Type
|
Free
|
Moderators |
VYCO Vycor Medical Inc.
Websites:
http://www.vycormedical.com/
http://www.novavision.com/
VYCO videos: http://player.vimeo.com/video/39903199
http://www.vycormedical.com/videos/videos.html
--------------------------------------------------------------------------------------------------------------------
About Vycor Medical Inc..
Vycor Medical, Inc. is a medical device company committed to making neurological brain, spinal and other surgical procedures safer and more effective. Vycor's innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery, and add tangible value to the professional medical community. The Cure Should Never Prove Worse Than the Condition.
Vycor Medical was founded on this basic challenge: "There must be a better way". A better way to access surgical locations without unduly damaging surrounding tissue. A less invasive means to perform critical procedures, so that collateral trauma can be minimized and postoperative recovery accelerated. And a better breed of surgical access instrumentation for enhancing performance, safety and results such as the Vycor ViewSite Surgical Access Systems, our premiere product line.
----------------------------------------------------------------------------------------------
TAKE A LONG HARD LOOK AT VYCO:
=====> VYCO's NovaVision technology is the only FDA cleared treatment that restores vision lost by victims of stroke and traumatic brain injury.
Vycor NovaVision product offering is the first real, tested, proven treatment for a type of vision loss which the medical community has considered untreatable for over a hundred years. NovaVision literally restores sight to the blind. VYCO has generated a legitimate medical breakthrough.
"NovaVision provides a home-based treatment of vision rehabilitation after stroke or brain injury called Vision Restoration Therapy (VRT™). VRT is an FDA-cleared, patented, non-invasive medical device that enhances visual functions in patients with impairments due to stroke, surgical intervention, and traumatic brain injury (TBI). "
"70% of cases patients using NovaVision's VRT system over a three to six month period experience significant recovery in at least one functional outcome. In many cases this recovery is enough to restore lost abilities such as reading, avoiding unseen objects while walking, or in some cases even driving a car."
"Stroke and traumatic brain injury (TBI) victims are almost always told by their doctors that vision loss causedby neurological brain damage is permanent and irreversible; these doctors have been taught this "fact" since early in their careers, and they mostly accept it as a fact, without question. However, according to six Company-sponsored studies and fourteen independent studies, conducted over a period of 15 years, this is not a fact at all. It is instead a previously-valid medical conclusion based on old data and technology - it is not based on current research. We believe the new data regarding recently-developed technology (i.e. NovaVision's VRT and NeET) have clearly shown that vision loss can be at least partially restored in most cases..."
Read up on the science and research here, including 15 years of research and 20 clinical studies: http://www.novavision.com/clinical-studies
Every year, 795,000 victims in the US alone suffer a stroke. http://www.cdc.gov/stroke/facts.htm
====> VYCO's ViewSite technology makes previously inoperable brain surgeries possible.
The ViewSite™ system is a revolutionary approach in brain retraction and access. It dramatically reduces the damage done by "retractors" used by neurosurgeons when reaching subsurface areas of the brain.
http://www.vycormedical.com/products/products.html
"The net effect of this is improved clinical outcomes, shorter surgeries, and shorter recovery times; in some cases this product's superior attributes have allowed brain surgeons to successfully perform surgeries that would have otherwise been considered inoperable."
VYCO technology is saving lives.
Doctor testimonials: http://www.vycormedical.com/products/testimonials.html
Clinical reports: http://www.vycormedical.com/products/reports.html
"Since its introduction in 2010, the ViewSite Brain Access System has been used to perform over 3,000 brain surgery procedures, and it has either been approved or is being evaluated by some 130 hospitals in the United States alone."
====> VYCO is penetrating a $20B international market.
"VYCOR Should Enter Hyper-growth During the Next Two to Three Years. Vycor's ViewSite is already making good inroads into the relatively small neurosurgery market, both in the U.S. and overseas, and we expect sales to grow robustly beginning in early 2013. However, we are most excited about the long-term potential of the NovaVisionsubsidiary, as its products have no real competition and address a global market that could be up to $20B in size. Although NovaVision's products could require several years to achieve market penetration of even 5%, this would still equate to a huge win for a company of this size. Both NovaVision and ViewSite have strong patent protection and backing from the scientific community, and both are FDA 510(k) cleared for sale in the United States." -- from the Harbinger Report
VYCO VRT treatment has already treated 2,000 patients. A $170,000 shipment was made to China in December, 2011. VYCO technology is already being used in hundreds of hospitals worldwide.
Vycor distributors are international, and aside from the US, include Australia, China, Japan, the Benelux, Greece, Italy, Spain, Sweden and the UK. 39% of revenue comes from sales outside the US, 32% of which is China. http://www.vycormedical.com/products/distributors.html
====> VYCO Revenues up. Forecasts call for revenues of $2.9mm in 2012, $5.3mm in 2013
"Revenue up 198% Over First Quarter 2011; Vycor Medical Division Revenue up 222% Over 2011, NovaVision Division up 145%; Net Loss Reduced"
http://finance.yahoo.com/news/vycor-medical-inc-reports-first-130000889.html
Harbinger Research report: http://a.eqcdn.com/harbingerresearch/media/b767cf61ff1d00bcf70bf414fab946a5.pdf
SEC filings: http://ir.vycormedical.com/SEC
====> VYCO has strong patent protection, FDA clearance for NoraVision and ViewSite, and little competition.
The Company has a very strong patent portfolio with 30 granted patents and 30 patents pending, providing it with significant IP protection and creating strong barriers to entry by would-be competitors.
More patent details here:http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76489668
FDA and regulatory: http://ir.vycormedical.com/FDA_and_Regulatory
NovaVision's VRT is the only FDA 510(k) cleared medical device that is used to restore visual field loss that results from neurological trauma.
====> VYCO team includes veteran industry management and international medical luminaries.
http://ir.vycormedical.com/profiles/investor/Management.asp?BzID=2090
The NovaVision advisory board reflects the caliber of international medical luminaries who resoundingly support Vycor's breakthrough technology. Alvaro Pascual-Leone, MD PhD is Professor of Neurology at Harvard Medical Shool. He is one of many highly respected medical leaders who warmly commend Vycor technology to their patients and peers
http://www.novavision.com/advisory-board-alvaro-pascual-leone
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |